Clinical Genome Resource 2024 Risk Allelic Variant Evidence Guidelines

**Semantic type:** Intellectual Product

**Definition:** Guidelines recommended in 2024 by the Low Penetrance/Risk Allele Working Group from the Clinical Genome Resource (ClinGen) for the interpretation and reporting of the pathogenicity of low-penetrance and/or low-risk allelic variants in clinical genomic and genetic testing.

**Synonyms:** - 2024 ClinGen Risk Allele Evidence Recommendations - ClinGen 2024 - ClinGen 2024 Low Penetrance/Risk Allelic Variant Interpretation Guidelines - ClinGene 2024 Risk Allele Evidence Guidelines